Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24‐Week, Phase III Study

BACKGROUND: This study evaluated the safety and efficacy of teduglutide in pediatric patients with short bowel syndrome–associated intestinal failure (SBS‐IF). METHODS: A 24‐week, phase III trial with 2 randomized, double‐blind teduglutide dose groups and a nonblinded standard of care (SOC) arm was...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocoshis, Samuel A., Merritt, Russell J., Hill, Susan, Protheroe, Susan, Carter, Beth A., Horslen, Simon, Hu, Simin, Kaufman, Stuart S., Mercer, David F., Pakarinen, Mikko P., Venick, Robert S., Wales, Paul W., Grimm, Andrew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318247/
https://www.ncbi.nlm.nih.gov/pubmed/31495952
http://dx.doi.org/10.1002/jpen.1690

Ejemplares similares

Ejemplares similares